Table 8.
Inherited/germline conditions involving arteriovenous malformations.
Associated malformation or syndrome | Inheritance | Clinical phenotype | Candidate gene | Protein function or suspected role (if known) | Clinical work-up | References |
---|---|---|---|---|---|---|
Hereditary Hemorrhagic Telangiectasia (HHT) aka Osler-Weber-Rendu Syndrome | AD | • Telangiectasias (lip, tongue, buccal mucosa, face, chest, and fingers) • AVMs throughout multiple sites including cerebral, pulmonary, gastrointestinal, and hepatic • Most common clinic manifestation epistaxis (starting age 12 usually) • Iron deficiency anemia • Heart failure • Stroke • GI bleed 25%, commonly after 50 |
ENG, ALK1/ACVRL1, GDF2 SMAD4/MADH4 |
• TGF-β signaling pathway | • CBC/iron studies • Sitting and supine pulse oximetry every 1–2 years during childhood • Contrast echo every 5 years by age 10 • Periodic endoscopy/colonoscopy to rule out GI polyps and malignant change of juvenile polyps • ENT evaluation • Brain MRI/MRA in infancy and after puberty • Liver US • Genetic testing and counseling • Antibiotic prophylaxis for dental and invasive procedure • Filter on IV lines to prevent bubbles if pulmonary AVM is present |
(3, 58, 59) |
CM-AVM1* | AD or sporadic | • Small, multifocal CMs often accompanied by a pale halo • 30% of cases associated with additional deeper, fast-flow AVMs |
RASA1
EPHB4 |
• Loss of function; encodes Ras GTPase activating protein p120RasGAP | • Brain/Spine imaging • Genetic testing and counseling • Screening echocardiography • X-rays for leg length discrepancy • ENT evaluation if epistaxis • US shows fast-flow lesion |
(3, 9, 11, 15, 20, 21) |
CM-AVM2* | Unknown, likely AD | • Small telangiectasias around the lips and on upper thorax • Less frequently cerebral AVMs |
EPHB4 | • Loss of function mutation. Transmembrane receptor preferentially expressed in endothelial cells, acts via RAS/MAPK pathway | • Brain/Spine imaging • Genetic testing and counseling • Screening echocardiography • X-rays for leg length discrepancy • ENT evaluation if epistaxis |
(12, 20, 21) |
Note that CM-AVM is classified under both capillary and arteriovenous malformation.